Trying times for Insys Therapeutics (NASDAQ:INSY) have finally come to an end—but at a price. On Friday, the opioid manufacturer said it has agreed to pay a whopping $225 million to settle criminal investigations. And yet, the market doesn’t seem to mind: INSY stock is up more than 10%.
Here’s everything we know.
INSY Stock: Turning Itself AroundAccording to prosecutors, Insys Therapeutics allegedly “engaged in prolonged, illegal conduct,” as it marketed opioids, a powerful and addictive painkiller, during a time when the number of fatalities in the US caused by fentanyl, a type ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.